In this article, we discuss 3 growth stocks gearing up for more gains.
It comes at a time when global stock markets are on high alert over Evergrande’s massive debt problems.
The Centers for Disease Control and Prevention on Friday endorsed the distribution of Pfizer and BioNTech’s Covid-19 booster shots to older Americans and other vulnerable people.
The positive data update has put the spotlight on a number of ETFs that could benefit from their high exposure to Johnson & Johnson.
Chinese property developer Evergrande has not said whether it will fulfil its interest payments to investors on its U.S.-dollar bond.
It worked once before in the stock market. Read More
As investors reel from Beijing’s regulatory crackdown, the fallout in areas like tutoring can be a guide to what went wrong, and where future opportunities lie.
This course has the objective that entrepreneurs from all over the country know how to establish their digital presence and take advantage of the opportunities offered...